Exercise alsoincreases sleep quality
in sleep apnea patients.
«Before this study, the recommendation to use neuraxial anesthesia
in sleep apnea patients was based on no scientific foundation,» said Dr. Memtsoudis.
Not exact matches
Breakthroughs
in everything from
patient monitoring to
sleep apnea are coming from Silicon Valley and could dramatically shift the current paradigm.
Physiologic studies also have shown that healthy infants are able to protect their airways and do not have increased
apnea when placed supine.20 Meyers and Herbst21 showed that the amount of gastroesophageal reflux
in healthy
patients was not significantly affected by changes
in sleep position.
While some over-the-counter mouthpieces are available online and
in stores, it is best to have them specially constructed by a dentist who has experience treating
sleep apnea and who will customize the mouthpiece for each
patient.
«Until we have further evidence on the efficacy of medical cannabis for the treatment of
sleep apnea, and until its safety profile is established,
patients should discuss proven treatment options with a licensed medical provider at an accredited
sleep facility,» said lead author Dr. Kannan Ramar, professor of medicine
in the division of pulmonary and critical care medicine at Mayo Clinic
in Rochester, Minnesota.
Sleep apnea may accelerate kidney function decline
in diabetic
patients with kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11 - 16 at the Pennsylvania Convention Center
in Philadelphia, PA..
«This study shows that a high - risk score for obstructive
sleep apnea is common
in non-dialysis CKD
patients with diabetic nephropathy and is associated with more rapid loss of renal function,» the investigators concluded.
In terms of diagnosis, doctors and
patients may attribute daytime tiredness to «just being pregnant» rather than to
sleep apnea.
A U-M pilot study published
in Sleep is the first to find an association between sleep apnea severity and cognitive dysfunction in patients wit
Sleep is the first to find an association between
sleep apnea severity and cognitive dysfunction in patients wit
sleep apnea severity and cognitive dysfunction
in patients with MS.
The Hospital for Special Surgery study is the first to provide evidence that an intervention during surgery can improve outcomes
in patients with
sleep apnea who often fare worse than
patients without this condition.
The new clinical trial, led by Braley and funded by the National Multiple Sclerosis Society, will investigate whether cognitive function
in MS
patients improves when
sleep apnea is treated.
A companion report was also released, titled «
In an age of constant activity, the solution to improving the nation's health may lie in helping it sleep better,» which summarizes the results of an online survey completed by patients currently being treated for obstructive sleep apnea (OSA
In an age of constant activity, the solution to improving the nation's health may lie
in helping it sleep better,» which summarizes the results of an online survey completed by patients currently being treated for obstructive sleep apnea (OSA
in helping it
sleep better,» which summarizes the results of an online survey completed by
patients currently being treated for obstructive
sleep apnea (OSA).
«Clinical trial underway to evaluate upper airway stimulation therapy for
sleep apnea in adolescent
patients with Down Syndrome.»
«Since obstructive
sleep apnea is a treatable condition that is also commonly seen
in MS, we wondered, «What if some of the thinking and processing difficulties that MS
patients experience do not stem directly from the MS itself, but from the effects of
sleep apnea or other
sleep problems?»»
People with MS face an elevated risk of obstructive
sleep apnea (OSA), a disorder
in which the throat collapses during
sleep, causing the
patient to repeatedly stop breathing for periods of 10 seconds or longer throughout the night.
In 2006, the ASA released guidelines recommending the use of regional anesthesia, when possible, in patients with sleep apnea undergoing surgery to reduce the use of systemic opioid
In 2006, the ASA released guidelines recommending the use of regional anesthesia, when possible,
in patients with sleep apnea undergoing surgery to reduce the use of systemic opioid
in patients with
sleep apnea undergoing surgery to reduce the use of systemic opioids.
«What comes with
sleep apnea are these changes
in the brain, so
in addition to prescribing continuous positive airway pressure, or CPAP — a machine used to help an individual
sleep easier, which is the gold standard treatment for
sleep disturbance — physicians now know to pay attention to helping their
patients who have these other symptoms,» Macey said.
They also calculated that diagnosing and treating every
patient in the U.S. who has
sleep apnea would produce an annual economic savings of $ 100.1 billion.
Now, the researchers will replicate their findings
in a larger sample of MS
patients, and treat those
patients diagnosed with obstructive
sleep apnea with positive airway pressure therapy (CPAP), the first - line treatment for OSA.
Obstructive
sleep apnea (OSA) is a condition where the walls of the throat relax and narrow during
sleep, resulting
in snoring and interrupting breathing, and it is common
in patients with Type 2 diabetes.
In future studies, the researchers hope to determine whether treating the
sleep apnea — using CPAP or other methods — returns
patients» brain chemicals back to normal levels.
«This study, for the first time, shows that the use of regional anesthesia improves outcomes
in patients with
sleep apnea undergoing total joint arthroplasty.
In the study, 73 adult
patients with moderate or severe
sleep apnea were divided into three groups.
«Our results also demonstrated an exposure - response relation
in that
patients with more severe
sleep apnea may have a higher risk of pneumonia than
patients with
sleep apnea of milder severity.»
Currently, up to 25 % of
patients presenting for surgery
in the United States have
sleep apnea.
A new study has found that reducing obstructive
sleep apnea (where
patients have difficulty
in breathing while asleep - often associated with loud snoring) can reduce the need to get up and pee at night (nocturia).
It's also the first study to show the size of the effect of positive pressure mask treatment (CPAP)
in patients with obstructive
sleep apnea (OSAS) on their nocturia symptoms.»
A novel device implanted under the skin like a pacemaker successfully treats central
sleep apnea (CSA)
in heart failure
patients, according to research presented today at the Heart Failure Congress 2014, held 17 - 20 May
in Athens, Greece.
In a landmark 2007 study, they performed tonsillectomies on 26 kids with OSA who showed signs of vascular dysfunction; after the operations cured their sleep apnea, arterial tissue returned to normal in 20 of the patient
In a landmark 2007 study, they performed tonsillectomies on 26 kids with OSA who showed signs of vascular dysfunction; after the operations cured their
sleep apnea, arterial tissue returned to normal
in 20 of the patient
in 20 of the
patients.
He said: «The remede ® system is the first fully implantable device to treat central
sleep apnea in heart failure
patients.
Another recent study, published last week
in the Journal of Clinical
Sleep Medicine, found that as many as 94 percent of adults with Down's syndrome had some sort of obstructive sleep apnea — and in 69 percent of those patients it was se
Sleep Medicine, found that as many as 94 percent of adults with Down's syndrome had some sort of obstructive
sleep apnea — and in 69 percent of those patients it was se
sleep apnea — and
in 69 percent of those
patients it was severe.
Timothy L. Smith, M.D., M.P.H., of Oregon Health & Science University, Portland, and colleagues investigated the impact of comorbid obstructive
sleep apnea (OSA) on CRS disease - specific QOL and
sleep dysfunction
in patients with CRS following functional endoscopic sinus surgery (FESS).
Similarly, only half of the
patients with OSA were categorized as being at high risk for OSA on the Berlin Questionnaire, a
sleep apnea screening tool, suggesting that these validated tools
in the general population may not be useful for
patients with cardiovascular diseases.
«Based on our findings, future studies are warranted to evaluate the utility of cardiopulmonary exercise testing for cardiovascular risk stratification
in patients with obstructive
sleep apnea.»
This can be done using a procedure called «drug - induced
sleep endoscopy» (DISE),
in which stepwise doses of anesthetic doses are given to put the
patient to
sleep and reproduce the airway obstruction causing
apnea.
In the largest study to date of the relationship between
sleep apnea and diabetes, a new study of more than 8,500 Canadian
patients has demonstrated a link between obstructive
sleep apnea (OSA) and the development of diabetes, confirming earlier evidence of such a relationship from smaller studies with shorter follow - up periods.
STATUS: An initial laboratory trial has shown ApneaApp to be just as effective as hooking up
patients to tracking instruments
in a
sleep clinic, the most common way to screen for
apnea.
Of the 1,000
patients included
in this analysis, 60 percent were male and the average age was 61; 49 percent had cardiac disease, 41 percent diabetes, 30 percent chronic kidney disease and 17 percent
sleep apnea.
The researchers evaluated their anesthetic technique
in 97
patients participating
in a study of robot - assisted surgery for severe
sleep apnea.
Total
apnea - hypopnea index (AHI)-- which measures severity of
sleep apnea by counting the number of pauses
in breathing during
sleep — for all
patients significantly decreased an average of 35 events per hour after the device was planted, which corresponds to an average reduction of 84 percent.
The 97
patients studied had severe
sleep apnea, with a median of 48
apnea - hypopnea events (complete or partial interruptions of breathing) per hour on standard testing
in the
sleep laboratory.
«Obesity - related illnesses, particularly obesity hypoventilation syndrome and
sleep apnea, may play a role
in the development of pulmonary hypertension, and so we examined whether the protective effects of obesity seen
in patients with heart failure were also seen
in these
patients,» said researcher Jose Caceres, MD, of Jacobi Medical Center / Albert Einstein College of Medicine
in the Bronx, NY.
The therapy, available since the early 1980s, almost guarantees relief from obstructive
sleep apnea symptoms, and research shows that it lower rates of cardiovascular disease and death
in patients who use it.
Results show that there was a significant reduction
in systolic and diastolic blood pressures among
sleep apnea patients who were compliant with CPAP therapy for three months.
Depressive symptoms were assessed using the validated
Patient Health Questionnaire (PHQ - 9), and the presence of obstructive
sleep apnea was determined objectively using overnight,
in - lab polysomnography.
However, clinically significant depressive symptoms remained
in only 4 percent of the
sleep apnea patients who adhered to CPAP therapy for 3 months (9 of 228
patients).
Both obstructive
sleep apnea (OSA) and insomnia are found
in a high percentage of
patients with a variety of neurological diseases, according to new...
A recent study by Drs. Thaler, O'Malley, Weinstein and other colleagues at Penn found that the TORS approach achieved a significant reduction
in the
apnea - hypopnea index (AHI)(an index used to assess the severity of
sleep apnea), a significant improvement
in minimum arterial oxygen saturation (the amount of oxygen
in your blood that maintains healthy organ functioning), and a significant improvement
in daytime drowsiness
in patients.
12/3/2008 Treating
Sleep Apnea in Alzheimer's Patients Helps Cognition Continuous positive airway pressure (CPAP) treatment seems to improve cognitive functioning in patients with Alzheimer's disease who also suffer from obstructive sleep apnea, according to the results of a randomized clinical trial conducted at the Un... Mo
Sleep Apnea in Alzheimer's Patients Helps Cognition Continuous positive airway pressure (CPAP) treatment seems to improve cognitive functioning in patients with Alzheimer's disease who also suffer from obstructive sleep apnea, according to the results of a randomized clinical trial conducted at the Un... Mo
Apnea in Alzheimer's
Patients Helps Cognition Continuous positive airway pressure (CPAP) treatment seems to improve cognitive functioning in patients with Alzheimer's disease who also suffer from obstructive sleep apnea, according to the results of a randomized clinical trial conducted at the Un...
Patients Helps Cognition Continuous positive airway pressure (CPAP) treatment seems to improve cognitive functioning
in patients with Alzheimer's disease who also suffer from obstructive sleep apnea, according to the results of a randomized clinical trial conducted at the Un...
patients with Alzheimer's disease who also suffer from obstructive
sleep apnea, according to the results of a randomized clinical trial conducted at the Un... Mo
sleep apnea, according to the results of a randomized clinical trial conducted at the Un... Mo
apnea, according to the results of a randomized clinical trial conducted at the Un... More...